MF
ATYR

Magnetar Financial’s aTyr Pharma ATYR Stock Holding History

Magnetar Financial’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,890
Closed -$440K – 402
2016
Q3 		$440K Hold
9,890
– – 0.01% 397
2016
Q2 		$385K Sell
9,890
-3,239
-25% -$151K 0.01% 262
2016
Q1 		$724K Sell
13,129
-178
-1% -$13.5K 0.01% 148
2015
Q4 		$1.83M Sell
13,307
-12,026
-47% -$1.71M 0.02% 112
2015
Q3 		$3.64M Buy
25,333
+3,272
+15% +$746K 0.05% 111
2015
Q2 		$5.72M Buy
+22,061
New +$6.85M 0.08% 130

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

Magnetar Financial's ATYR Position: Q4 2016 in Review

Magnetar Financial sold out of aTyr Pharma (ATYR) in Q4 2016, closing a stake of 9,890 shares — an estimated $440K sold.

Magnetar Financial first reported a position in ATYR in Q2 2015 and held it in 6 quarters. The position peaked at $5.72M in Q2 2015. 52 funds tracked by Wall St. Rank hold ATYR as of Q4 2016.

  • Magnetar Financial reported no remaining aTyr Pharma position as of Q4 2016 after selling out during the quarter.
  • Magnetar Financial sold 9,890 aTyr Pharma shares in Q4 2016, an estimated $440K.
  • Magnetar Financial first reported a position in aTyr Pharma in Q2 2015 and held it in 6 quarters.
  • Magnetar Financial's aTyr Pharma position peaked at $5.72M in Q2 2015.
  • 52 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2016.

Based on Magnetar Financial's 13F filing for Q4 2016, filed 14 Feb 2017.